Technical Analysis for PIQ - Proteomics International LaboratoriesLtd
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 1.050 | -1.41% | -0.015 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -1.41% | |
| Oversold Stochastic | Weakness | -1.41% | |
| Oversold Stochastic | Weakness | 0.48% | |
| Inside Day | Range Contraction | -3.67% | |
| Oversold Stochastic | Weakness | -3.67% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 2 days ago |
| Down 3% | 2 days ago |
| Down 2% | 2 days ago |
| Down 1% | 2 days ago |
| Up 2% | 3 days ago |
Get this analysis on your stocks daily!
Proteomics International LaboratoriesLtd Description
Proteomics International Laboratories Limited is a biological research and drug discovery company. The Company operates in three business units unified by a technology platform: Analytical services, which includes specialist contract research, analytical testing and consultancy; Diagnostics, which includes biomarkers of disease and personalized medicine, and Therapeutics, which includes peptide drug discovery from venoms. The Company focuses on the PromarkerD, a proteomics-derived predictive and diagnostic test for diabetic kidney disease. The Company focuses on its diagnostics portfolio using the Promarker platform, and is investigating proteins associated with endometriosis, mesothelioma and other conditions. The Company has a therapeutic drug discovery program targeting new analgesic (painkilling) and antibiotic drug compounds. The Company also has a laboratory to analyze the make-up of biosimilar drugs as being like-for-like with the brand name drugs they seek to replace.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Disease Drugs Clinical Medicine Life Sciences Pound Protein Drug Discovery Laboratory Peptide Proteins Antibiotic Biomarkers Omics Biomarker Personalized Medicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.4 |
| 52 Week Low | 0.7 |
| Average Volume | 310,447 |
| 200-Day Moving Average | 0.949 |
| 50-Day Moving Average | 1.122 |
| 20-Day Moving Average | 1.136 |
| 10-Day Moving Average | 1.082 |
| Average True Range | 0.057 |
| RSI (14) | 41.86 |
| ADX | 16.91 |
| +DI | 17.754 |
| -DI | 29.520 |
| Chandelier Exit (Long, 3 ATRs) | 1.124 |
| Chandelier Exit (Short, 3 ATRs) | 1.191 |
| Upper Bollinger Bands | 1.267 |
| Lower Bollinger Band | 1.006 |
| Percent B (%b) | 0.17 |
| BandWidth | 22.975 |
| MACD Line | -0.020 |
| MACD Signal Line | -0.008 |
| MACD Histogram | -0.012 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.103 | ||||
| Resistance 3 (R3) | 1.098 | 1.077 | 1.094 | ||
| Resistance 2 (R2) | 1.077 | 1.063 | 1.079 | 1.091 | |
| Resistance 1 (R1) | 1.063 | 1.055 | 1.068 | 1.068 | 1.088 |
| Pivot Point | 1.042 | 1.042 | 1.044 | 1.044 | 1.042 |
| Support 1 (S1) | 1.028 | 1.028 | 1.033 | 1.033 | 1.012 |
| Support 2 (S2) | 1.007 | 1.020 | 1.009 | 1.009 | |
| Support 3 (S3) | 0.993 | 1.007 | 1.006 | ||
| Support 4 (S4) | 0.998 |
